Literature DB >> 3976659

Fra(10)(q25): the BrdU effect is substitution-dependent.

S M Gollin, G P Holmquist, D H Ledbetter.   

Abstract

Expression in the majority of fra(10)(q25) cases is either induced or enhanced by the presence of bromodeoxyuridine (BrdU) in the culture medium. BrdU is known to exert its effects on cells via two primary mechanisms: substitution-dependent and concentration-dependent. BrdU incorporation into DNA and BrdU concentration in the culture medium can be resolved as independent variables. The results of such experiments indicate that at three fixed levels of BrdU substitution, 100-fold variation of BrdU concentration had little or no effect on fra(10)(q25) expression. At a fixed BrdU concentration, the level of fra(10)(q25) expression rises as a function of increased BrdU substitution, approaching 100% expression at 100% substitution. Thus, BrdU induction or enhancement of fra(10)(q25) expression is clearly substitution-dependent. Iododeoxyuridine, another halogenated pyrimidine, has a similar effect. The critical time of incorporation is between 8 and 9 hrs before mitosis. After this time, removal of BrdU (and fluorodeoxyuridine [FdU]) from the culture medium followed by addition of deoxythymidine does not reverse the BrdU effect on fra(10)(q25) expression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976659      PMCID: PMC1684554     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

Review 1.  The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells.

Authors:  B Goz
Journal:  Pharmacol Rev       Date:  1977-12       Impact factor: 25.468

2.  Expression of fragile site at 10q25 in normal culture conditions.

Authors:  P Petit; J P Fryns
Journal:  Am J Hum Genet       Date:  1983-01       Impact factor: 11.025

3.  Genetic length of a human chromosomal segment measured by recombination between two fragile sites.

Authors:  G R Sutherland; E Baker; J C Mulley
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

4.  Bromodeoxyuridine mutagenesis in mammalian cells is stimulated by thymidine and suppressed by deoxycytidine.

Authors:  R L Davidson; E R Kaufman
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

5.  Bromodeoxyuridine mutagenesis in mammalian cells: mutagenesis is independent of the amount of bromouracil in DNA.

Authors:  E R Kaufman; R L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Spontaneous expression of the chromosome fragile site fra(10)(q25).

Authors:  A M Taylor; S Bundey
Journal:  Am J Hum Genet       Date:  1983-01       Impact factor: 11.025

7.  Inhibition of Friend erythroleukemic cell differentiation by bromodeoxyuridine: correlation with the amount of bromodeoxyuridine in DNA.

Authors:  C R Ashman; R L Davidson
Journal:  J Cell Physiol       Date:  1980-01       Impact factor: 6.384

8.  Induction of sister chromatid exchanges by BUdR is largely independent of the BUdR content of DNA.

Authors:  R L Davidson; E R Kaufman; C P Dougherty; A M Ouellette; C M DiFolco; S A Latt
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

9.  Bromodeoxyuridine mutagenesis in mammalian cells is related to deoxyribonucleotide pool imbalance.

Authors:  C R Ashman; R L Davidson
Journal:  Mol Cell Biol       Date:  1981-03       Impact factor: 4.272

10.  Heritable fragile sites on human chromosomes. V. A new class of fragile site requiring BrdU for expression.

Authors:  G R Sutherland; E Baker; R S Seshadri
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.